Moxetumomab pasudotox-tdfk Intravenous and Risperdal Consta
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Risperdal Consta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: risperidone
Brand name: Perseris, Risperdal Consta, Risperdal Consta, Risperdal, Risperdal M-Tab
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Risperdal M-Tab
- Moxetumomab pasudotox-tdfk Intravenous-Risperidone
- Moxetumomab pasudotox-tdfk Intravenous-Risperidone injection
- Moxetumomab pasudotox-tdfk Intravenous-Risperidone Injection (IM)
- Moxetumomab pasudotox-tdfk Intravenous-Risperidone Injection (Subcutaneous)
- Moxetumomab pasudotox-tdfk Intravenous-Risperidone Intramuscular
- Risperdal Consta-Moxifloxacin
- Risperdal Consta-Moxifloxacin (Systemic)
- Risperdal Consta-Moxifloxacin Hydrochloride
- Risperdal Consta-Moxifloxacin Injection
- Risperdal Consta-Moxifloxacin Intravenous
- Risperdal Consta-Moxifloxacin Tablets